Effect of early administration of dexamethasone in patients with COVID-19 pneumonia without acute hypoxemic respiratory failure and risk of development of acute respiratory distress syndrome: EARLY-DEX COVID-19 trial

  1. Franco-Moreno, A.
  2. Acedo-Gutiérrez, M.S.
  3. Casado-Suela, M.Á.
  4. Labrador-San Martín, N.
  5. de Carranza-López, M.
  6. Ibáñez-Estéllez, F.
  7. Hernández-Blanco, C.
  8. Jiménez-Torres, J.
  9. Vallejo-Maroto, I.
  10. Romero-Pareja, R.
  11. Peña-Lillo, G.
  12. Escobar-Rodríguez, I.
  13. Torres-Macho, J.
Aldizkaria:
Frontiers in Medicine

ISSN: 2296-858X

Argitalpen urtea: 2024

Alea: 11

Mota: Artikulua

DOI: 10.3389/FMED.2024.1385833 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus